B. Wallace

发表

Targeted inhibition of gut bacterial β-glucuronidase activity enhances anticancer drug efficacy

David B. Darr, I. Wilson, J. Roach, 2020, Proceedings of the National Academy of Sciences.

Hydration changes accompanying the binding of minor groove ligands with DNA.

N. Degtyareva, J. Petty, Kristine M Loo, 2007, Biophysical journal.

CHARACTERIZATION OF THE N -ACETYL- α -D-GLUCOSAMINYL L-MALATE SYNTHASE (BshA) AND DEACETYLASE (BshB) FUNCTIONS FOR BACILLITHIOL BIOSYNTHESIS IN Bacillus anthracis

M. Redinbo, G. Newton, D. Parsonage, 2011 .

Molecular basis for processing of topoisomerase 1-triggered DNA damage by Apn2/APE2

T. Kunkel, J. Wojtaszek, J. Krahn, 2022, Cell reports.

Structure and Inhibition of Microbiome β-Glucuronidases Essential to the Alleviation of Cancer Drug Toxicity.

S. Frye, L. Kelly, C. Pepe-Ranney, 2015, Chemistry & biology.

Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme

Matthew R. Redinbo, John E Scott, Hongwei Wang, 2010, Science.

APE2 Zf-GRF facilitates 3′-5′ resection of DNA damage following oxidative stress

J. Wojtaszek, R. London, G. Mueller, 2016, Proceedings of the National Academy of Sciences.

Molecular Insights into Microbial β-Glucuronidase Inhibition to Abrogate CPT-11 Toxicity

M. Redinbo, S. Mani, M. Venkatesh, 2013, Molecular Pharmacology.

Pharmacologic Targeting of Bacterial β-Glucuronidase Alleviates Nonsteroidal Anti-Inflammatory Drug-Induced Enteropathy in Mice

M. Redinbo, U. Boelsterli, B. D. Wallace, 2012, Journal of Pharmacology and Experimental Therapeutics.

Virtual Screening for the Discovery of Microbiome β-Glucuronidase Inhibitors to Alleviate Cancer Drug Toxicity

M. Hall, Hongmao Sun, Xin Hu, 2022, J. Chem. Inf. Model..

Recognition and repair of chemically heterogeneous structures at DNA ends

M. Schellenberg, R. S. Williams, S. N. Andres, 2015, Environmental and molecular mutagenesis.

Endogenous DNA 3' Blocks Are Vulnerabilities for BRCA1 and BRCA2 Deficiency and Are Reversed by the APE2 Nuclease.

D. Durocher, Jordan T. F. Young, J. Wojtaszek, 2020, Molecular cell.

Alleviating Cancer Drug Toxicity Through Targeted Inhibition of a Bacterial Enzyme and Exploring the Structural and Functional Properties of the Xenobiotic Nuclear Receptor PXR

B. Wallace, 2012 .

Structural and functional analysis of the human nuclear xenobiotic receptor PXR in complex with RXRα.

L. Betts, M. Redinbo, B. D. Wallace, 2013, Journal of molecular biology.

Turnover-dependent covalent inactivation of Staphylococcus aureus coenzyme A-disulfide reductase by coenzyme A-mimetics: mechanistic and structural insights.

M. Redinbo, E. Strauss, A. Claiborne, 2012, Biochemistry.

Ribonucleotide triggered DNA damage and RNA-DNA damage responses

Scott Williams, R. S. Williams, B. Wallace, 2014, RNA biology.

Xenobiotic-sensing nuclear receptors involved in drug metabolism: a structural perspective

M. Redinbo, B. D. Wallace, B. Wallace, 2013, Drug metabolism reviews.

The human microbiome is a source of therapeutic drug targets.

M. Redinbo, Matthew R Redinbo, Bret D Wallace, 2013, Current opinion in chemical biology.

Characterization of the N-acetyl-α-D-glucosaminyl l-malate synthase and deacetylase functions for bacillithiol biosynthesis in Bacillus anthracis .

M. Redinbo, G. Newton, D. Parsonage, 2010, Biochemistry.

Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme

John E. Scott, M. Redinbo, S. Mani, 2010, Science.

Structure of the sirtuin‐linked macrodomain SAV0325 from Staphylococcus aureus

C Denise Appel, Geoffrey K Feld, Bret D Wallace, 2016, Protein science : a publication of the Protein Society.